What Hyperfine does

Hyperfine, Inc. is a publicly traded medical technology company (NASDAQ: HYPR) headquartered in Guilford, Connecticut that developed the Swoop system, the world's first FDA-cleared portable ultra-low-field (0.064T) brain MRI system. The company's core technology pairs a miniaturized 0.064T magnet with Optive AI, a deep learning image reconstruction software that compensates for the inherently lower signal-to-noise ratio of ultra-low-field MRI to produce diagnostic-quality brain images. The Swoop system can be plugged into a standard outlet and operated in minutes by a trained clinician without requiring a dedicated MRI room, specialized technician, or fixed infrastructure, enabling point-of-care imaging in hospital ICU/ED settings, outpatient neurology clinics, pediatric facilities, and resource-constrained environments in low- and middle-income countries.

The product portfolio includes the original Swoop system (FDA-cleared 2020), the next-generation Swoop system (FDA-cleared Q2 2025 with CE Mark and UKCA approval in April 2026), and the Optive AI software platform with multiple iterative FDA clearances including a December 2025 multi-direction diffusion-weighted imaging update for enhanced stroke detection. Hyperfine generates revenue primarily through one-time hardware sales of the Swoop system, with pricing conducted on a quote-based enterprise model; pricing is not publicly disclosed. Go-to-market combines a direct enterprise sales force targeting US hospitals and neurology clinics with a distributor network spanning more than a dozen international markets, including exclusive partnerships with Radiosurgery Global (India) and Lioness Medtech (Nordics). Selected customers include Jefferson Abington Hospital (the highest-volume US site with 1,000+ scans), CHRISTUS Mother Frances, Atlantic Health's Morristown Medical Center, Neurology of Central Florida, and AIIMS New Delhi. Reported revenue was $13.56 million in FY2025 (5.2% YoY growth), with Q1 2026 revenue of $3.90 million (+83% YoY), FY2026 guidance of $20-22 million (~55% growth at midpoint), and gross margins improving to 51% in Q1 2026 from 41% in the prior-year quarter. Capital structure includes approximately $35 million in cash as of December 2025, a $40 million debt facility from Horizon Technology Finance (March 2026) extending runway into 2028, and two post-IPO equity raises in 2025 totaling $23.5 million.

Name

Hyperfine

Legal name

Hyperfine, Inc.

Website

https://hyperfine.io

Company type

Public

Founded year

2014

Operating status

Operating

Headcount range

101–250 employees

Short description

Hyperfine develops and commercializes the Swoop portable ultra-low-field (0.064T) brain MRI system and Optive AI image reconstruction software, serving hospitals, neurology clinics, and pediatric settings with point-of-care diagnostic imaging.

Ownership category

akta.pro rank

Product category

Medical Imaging Equipment

NAICS

Diagnostic Imaging Centers (621512), Computer Systems Design and Related Services (54151)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Portable, Mobile & Point-of-Care Imaging Systems (HLAHABAL)

akta.pro secondary industries

Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ), Medical Imaging AI (HDAAAEAH), AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG), Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity) (HLACABAM)

Keywords

• Portable MRI systems
• Brain imaging devices
• Point-of-care MRI
• AI medical imaging
• Ultra-low-field MRI

Headquarters

HQ city

Guilford

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Swoop System Sales: Sale of the Swoop portable MRI system to healthcare institutions including hospitals, neurology clinics, and pediatric facilities. Revenue is recognized upon system delivery and installation.
2. Optive AI Software: AI-powered image reconstruction software integrated with the Swoop system, enabling advanced imaging capabilities and diagnostic quality at ultra-low field strengths.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Hyperfine designs, manufactures, and sells the Swoop Portable MR Imaging System, an AI-powered, FDA-cleared ultra-low-field (0.064 Tesla) brain MRI that can be wheeled to the point of care in hospitals, neurology clinics, and pediatric settings without dedicated MRI infrastructure or specialized technicians. The system is powered by Optive AI software, which uses deep-learning image reconstruction to reduce noise and blur and produce diagnostic-quality brain imaging at very low field strength. Revenue is generated through one-time capital equipment sales of the Swoop hardware system, with companion Optive AI software delivering advanced imaging sequences including T1, T2, FLAIR, and multi-direction diffusion-weighted imaging.

Product overview

Hyperfine offers a unified portable MRI portfolio centered on the Swoop system, an AI-powered portable brain MRI device that uses ultra-low-field (0.064T) technology and can be deployed at the point of care across hospitals, neurology clinics, and pediatric settings without dedicated MRI infrastructure. The system is powered by Optive AI software, which provides deep learning-based image reconstruction to enhance image clarity. The product line includes the original Swoop system and the next-generation Swoop system (with improved image quality, workflow, and user experience). The system supports multiple imaging sequences including T1, T2, FLAIR, and diffusion-weighted imaging (DWI), with the latest Optive AI software update adding multi-direction DWI capabilities for enhanced stroke detection.

Differentiator

Problem solved

Functional benefit

Brands

• Swoop: AI-powered portable MR imaging system for point-of-care brain imaging
• Optive AI
• Portable MR Imaging

Products and services

• Swoop Portable MR Imaging System AI-powered, FDA-cleared portable brain MRI system using ultra-low-field (0.064 Tesla) technology that can be wheeled to the point of care in hospitals (ICU, emergency department), neurology clinics, and pediatric settings without requiring dedicated MRI infrastructure, shielded rooms, or specialized MRI technicians. The system plugs into a standard outlet, sets up in minutes, and operates with an intuitive interface usable by trained healthcare professionals. Supports T1, T2, FLAIR, DWI, and multi-direction diffusion-weighted imaging sequences in axial, coronal, and sagittal planes.
• Optive AI Software AI-driven image reconstruction software powering the Swoop system, using deep learning to reduce noise and blur and enhance image clarity and consistency at ultra-low-field (0.064T) strength. Delivers sharper anatomical detail to support confident diagnoses at the point of care and includes multi-direction diffusion-weighted imaging for enhanced stroke detection.
• Next-Generation Swoop System Upgraded version of the Swoop portable MRI system with substantial improvements in image quality, workflow, and user experience. FDA-cleared in Q2 2025 and CE Mark/UKCA-approved in April 2026 for international commercialization across Europe, the UK, and other markets through the existing distributor network spanning over a dozen countries.

Quantifiable outcome

• Reduced median time from imaging order to scan start from 7.76 hours to 1.28 hours in emergency department settings (6.35 hour difference)
• +4 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Partnerships

Three partnerships are on record, tiered regional and core.

• Lioness Medtech ABregionalChannel Partner/ Reseller/ Distributor · 10 March 2026Exclusive Nordic distributor for Swoop portable MRI system. Participation in Akutveckan 2026 medical conference in Stockholm to showcase the system. First clinical systems being introduced in the Nordic region.
• Radiosurgery Global Ltd.coreChannel Partner/ Reseller/ Distributor · 20 January 2026Exclusive Indian distributor partnership for Swoop portable MRI system. Enabled regulatory approval from India CDSCO and deployment at AIIMS New Delhi as first Indian hospital to deploy bedside brain imaging.
• King's College LondoncoreStrategic or Co-development Partner · 19 November 2025Lead institution for UNITY project, coordinating activities across 40+ academic and clinical centers in multiple countries. Project developing AI pipelines to improve image quality and diagnostic reliability for neonatal patients using Hyperfine's Swoop system.

Scale indicators9 records

Recent moves6 records

Expansion highlights7 records

Broad incumbents

• GE HealthCare: One of the world's largest MRI manufacturers with deep hospital relationships and a broad imaging portfolio. While not focused exclusively on portable MRI, GE HealthCare is the most likely incumbent to launch a competing point-of-care brain MRI solution given its scale and R&D resources.
• Siemens Healthineers: Global MRI market leader with MAGNETOM product family and extensive hospital installed base. Siemens has the engineering depth to enter portable/point-of-care MRI and would represent the most formidable competitive threat to Hyperfine's niche.
• Philips Healthcare: Major MRI manufacturer with strong neurology and critical care positioning. Philips' strength in integrated diagnostic workflows and ICU/ED solutions makes it a direct strategic competitor in the point-of-care imaging space Hyperfine is targeting.
• Canon Medical Systems: Established MRI manufacturer with Vantage Galan and other 1.5T/3T systems serving hospital radiology departments. Canon has the installed base and clinical relationships to expand into portable imaging if the market develops.
• Fujifilm Healthcare: Diversified imaging manufacturer with MRI systems and growing point-of-care portfolio. Fujifilm's expansion into portable diagnostics and AI-assisted imaging makes it a relevant competitive and adjacent technology peer.
• United Imaging Healthcare: Chinese-based global MRI manufacturer rapidly expanding in international markets, particularly emerging economies. Represents both a potential competitor and parallel player in democratizing MRI access globally.

Direct peers

• Samsung Neurologica: Subsidiary of Samsung Electronics that pioneered portable CT scanners (BodyTom, OmniTom) for point-of-care neuroimaging. Most directly comparable peer given its focus on bringing imaging to the bedside in critical care settings, though in CT rather than MRI.

Emerging players

• Butterfly Network: Publicly traded handheld ultrasound company using semiconductor-based probe technology and AI for image interpretation. Highly comparable go-to-market motion targeting point-of-care diagnosis with affordable, portable AI-enabled imaging, though in ultrasound rather than MRI.
• Exo Imaging: Developer of handheld ultrasound with AI for point-of-care use. While in a different modality, Exo represents a parallel disruptive play in portable AI-enabled imaging targeting similar clinical use cases and care settings as Hyperfine.

Others

• Tempus AI: AI-enabled healthcare technology company with imaging analytics and radiology AI capabilities. While not a hardware competitor, Tempus AI represents an adjacent player building AI infrastructure for medical imaging that could partner with or compete against Hyperfine's Optive AI software layer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/hyperfine
• Facebookfacebook.com/Hyperfine
• LinkedInlinkedin.com/company/hyperfine-inc
• Instagraminstagram.com/hyperfine

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Funding overview

Funding rounds9 records

Investors20 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hyperfine